MedPath

Investigation of the transdermal absorption effect of clary sage essential oil on hot flashes of menopausal wome

Phase 1
Conditions
Menopause(hot flashes)
Registration Number
JPRN-UMIN000024894
Lead Sponsor
Yokohama City University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

(1)HRT was enforced within 30 days before the start of the study. (Women 's medicine and supplements of Chinese herbal medicine and general medicine not containing estrogen preparation are acceptable.) (2)Allergy against essential oil used (3)There is skin disease (4)HRT and Surgical menopause treatment is in effect (5)Menopausal symptom interview sheet (Document IV) There are other diseases that fall under Q4 (2) - (16) (not limited to the presence or absence of treatment) (6)Participate in other exams within 30 days before the exam (7)In addition, patients judged unsuitable as subjects by doctor's judgment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluate the following items 21 days after the start of intervention. Symptom change of hot flashes: Evaluation of change occurring in the number of times and degree of hot flash by hot flash memory. Estrogenic activity: For each test, about 20 ml of urine is collected on the first day and the last day of the test and E2, FSH, LH are chromatographed, and the difference in hormone levels occurring between the intervention group and the control group is evaluated. Physical symptom change of menopausal disorder: Relative evaluation in somatic symptom change of 14 items described in hot flash memory
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath